| 注册
首页|期刊导航|中国药物评价|止血药的临床应用分析

止血药的临床应用分析

曹迪

中国药物评价2016,Vol.33Issue(4):216-218,3.
中国药物评价2016,Vol.33Issue(4):216-218,3.

止血药的临床应用分析

Analysis on Clinical Application of Hemostatics

曹迪1

作者信息

  • 1. 安徽省蚌埠市第三人民医院药学部,安徽蚌埠233000
  • 折叠

摘要

Abstract

Objective:Tolearnthe characteristics and trends of the application of hemostatics in our hospital.Methods:A retrospective analysis was made on data of hemostatics sales amount, DDDs, DDC, order of sales amount/order of DDDs ( A/B) of hospitalized pa-tients application of hemostatics in 2014.Results:The sales amount of hemocoagulase ranks highest.The top three are etamsylate, hemo-coagulase, vitamin K1 in DDDs sequence.Tranexamic acid ranks the order of DDDs of anti-plasmin.Etamsylate has a high value of A/B but a low DDC.Conclusion:Inpatients of our hospital are mainly treated with hemostatics medicine with effect of procoagulant such as hemocoagulase in particular.It should strengthen the clinical rational use of hemostatics in the perioperative period of surgery.

关键词

止血药/药物利用/合理用药

Key words

Hemostatic/Medication tendency/Rational drug use

分类

医药卫生

引用本文复制引用

曹迪..止血药的临床应用分析[J].中国药物评价,2016,33(4):216-218,3.

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文